-+ 0.00%
-+ 0.00%
-+ 0.00%

POLARYX THERAPEUTICS, INC - TO INITIATE SOTERIA TRIAL IN Q3 2026 FOLLOWING FDA SAFE TO PROCEED LETTER

Reuters·03/17/2026 12:30:03

Please log in to view news